StockData
Adagene Inc. logo

Adagene Inc. (ADAG) stock

ADAGNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 1, 2026Score 5/30
$1.48−0.12 (-7.50%)

Close on Nov 17, 2026Market cap $87.66MP/E –Yield –

Adagene cash

Cash and short-term investments held at the end of each period.

Adagene's cash was $127.91M at Jun 30, 2026. For fiscal 2025 it was $74.52M, down 12.5% from the year before. The highest annual figure on record is $174.39M in fiscal 2021.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$74.52M-12.5%
FY2024Dec 31, 2024$85.19M-22.5%
FY2023Dec 31, 2023$109.93M-23.5%
FY2022Dec 31, 2022$143.76M-17.6%
FY2021Dec 31, 2021$174.39M+132.1%
FY2020Dec 31, 2020$75.15M-25.2%
FY2019Dec 31, 2019$100.53M+526.0%
FY2018Dec 31, 2018$16.06M+83.8%
FY2017Dec 31, 2017$8.74M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$127.91M+33.7%
Q4 FY2025Dec 31, 2025$74.52M-32.2%
Q2 FY2025Jun 30, 2025$62.83M-51.2%
Q4 FY2024Dec 31, 2024$85.19M-40.7%
Q2 FY2024Jun 30, 2024$95.67M-45.1%
Q4 FY2023Dec 31, 2023$109.93M+46.3%
Q2 FY2023Jun 30, 2023$128.76M+28.1%
Q4 FY2022Dec 31, 2022$143.76M+795.2%
Q4 FY2021Dec 31, 2021$174.39M+1896.2%
Q4 FY2020Dec 31, 2020$75.15M–
Q4 FY2019Dec 31, 2019$100.53M–
Q4 FY2018Dec 31, 2018$16.06M–
Q4 FY2017Dec 31, 2017$8.74M–

More Adagene figures

See a number that looks wrong?